StockTipsArenaBeta

BUY Dr. Lal Path Labs Ltd. — Kunal Bothra

BUYDr. Lal Path Labs Ltd.
Dr. Lal Path Labs share price target & all analyst calls

byKunal BothraHorizon: Swing (≤2wk)9 Oct 2026via NDTV Profit (Live)

Entry₹1,936.7Inferred
Target₹1,990
Total upside +2.75%
Stop loss₹1,875-3.19% risk
CMP₹1,933.6Just now
Active-0.16%+2.92%upside left 14d left
Follow Kunal Bothra for new calls(30% target hit, 259 closed calls)Get alertsWatch LALPATHLAB for new buy/sell callsGet alertsSee 227 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Oct, 4:45 pm IST
3 supporting0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·9 Oct · today

Dr. Lal PathLabs Ltd announces the completion of its acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, through its wholly-owned subsidiary DLPL Dubai. Sunshine Healthcare Limited is n

BSE · Company Update·26 Sept · 2w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·19 Aug · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Lal Path Labs

All analyst calls on Dr. Lal Path Labs

More from Kunal Bothra

Every call and its outcome